Easton implements innovation-driven strategy for achieving sustainable development, by emphasizing on constant improvement of R&D system. The R&D Center of Easton is certified as "Industry technical center of Sichuan Province" by the Sichuan Economic and Information Commission and five other Departments. It has established a post-doctoral research workstation in Chengdu High-tech Zone, which was approved by the China Doctor Management Office. The key technology platforms established include drug crystal technology platform, controlled release technology platform, special drug technology platform, innovative drug technology platform, clinical trial platform, focusing on the main areas of anti-cancer, diabetes, cardiovascular, anesthesia and analgesia, pediatric drugs etc. Our company adheres to the strategy of innovative and sustainable development, upholding the principle of being innovation-driven, product-oriented, proficiency-guaranteed and efficiency-centric.
R&D center of the company has a top R&D team for new drugs and generic drugs. It has complete and advanced R&D equipment, including mass spectrometer, X-ray diffractometer, high performance liquid chromatography, gas chromatography, liquid chromatography-mass spectrometer, multi-purpose fluidized bed, differential scanning calorimeter and other so on. It also has an independent pilot and scale-up workshop, which can undertake new drugs from lab scale to commercial scale.